Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Sichuan Kelun Pharma to Stage $735 Million IPO in Shenzhen

publication date: May 21, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Sichuan Kelun Pharmaceutical Co., a major manufacturer of IV solutions, announced its plans to raise 5 billion RMB ($735 million) in an IPO on the Shenzhen exchange. The company will issue 60 million A-shares, about 25% of its outstanding shares, at a price of 83.36 RMB ($12.26). Founded in 1996, Kelun’s revenues topped $382 million in 2008. Taxable profit was $88 million. More details...

Stock Symbol: (SZEX: 002422)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors